Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
A Single-Dose, Four-way-Crossover Comparative Bioavailability Study of Two Omega-3 Formulations under Fasting and Fed Conditions in Healthy Volunteers133
Treatment Gap in Prevention of Myocardial Infarction in Rural New York State129
News from NLA117
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine94
The Effect of Estrogen and Testosterone on Cholesterol Crystallization66
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease62
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice61
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis56
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis52
Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly-diagnosed metastatic pancreatic adenocarcinoma49
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia48
Assessment of health disparities in secondary ASCVD risk prevention in the elderly population in Greece47
Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice45
Lipoprotein(a) concentrations across a global cross-sectional registry44
Disparities in statin use among individuals with and without cancer history across atherosclerotic cardiovascular disease risk categories42
Care of youth with lipid disorders: A brief provider survey40
Genetic mutations and associated phenotypes in familial hypercholesterolemia: A biobank study40
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery36
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor34
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss30
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study28
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes28
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia28
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse27
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease27
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-1925
0.076194047927856